Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:27:10.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new Study Protocol and Statistical Analysis Plan link is added under Study Documents, along with IPD sharing information and related study metadata. The update also introduces associated keywords and MeSH terms (e.g., Pembrolizumab, Rituximab, Waldenström's Macroglobulinemia) to improve searchability and context.
    Difference
    59%
    Check dated 2026-09-27T18:15:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previously visible study record content. This indicates the study details are currently inaccessible rather than updated content.
    Difference
    19%
    Check dated 2026-09-20T19:32:28.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page adds an NIH grant/funding reference for 2018 and updates the page revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T21:57:04.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.4 to v3.6.5, signaling a new page version. This is a metadata update, not a modification to study data or content.
    Difference
    0.0%
    Check dated 2026-08-09T09:16:21.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.3 to v3.6.4, indicating an incremental version update. It does not appear to alter study data or eligibility details.
    Difference
    0.0%
    Check dated 2026-07-25T17:06:19.000Z thumbnail image

Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.